Head of Computational Clinical Imaging
Centre for the Unknown, Chapalimaud Foundation
Nickolas Papanikolaou, PhD (Male), is a Principal Investigator in Oncologic Imaging and research group leader of the Computational Clinical Imaging Group in the Centre for the Unknown at Champalimaud Foundation, Lisbon, Portugal. He has appointed as the Machine Learning Imaging Lead for the AI Hub at Royal Marsden and recognized as an honorary reader at the Institute of Cancer Research, in London, UK. He is also an Affiliated Researcher at Karolinska Institute and a Senior Affiliated Researcher at the Institute of Computer Science – FORTH. Dr. Nikolaos Papanikolaou studied biomedical engineering while he obtained his Ph.D. from the Medical School of the University of Crete. He has published 170 scientific papers in peer-reviewed international journals, 17 chapters in international books. At the same time, he edited a series of 3 books on Diffusion-Weighted Imaging Applications in GI, GU, and Hepatobiliary systems. He has delivered more than 130 invited lectures in international congresses and educational courses. He served as a member of the editorial board of European Radiology in the section of experimental radiology while he was a member of the abdominal subcommittee of ECR. He has been awarded two research scholarships from ECR. Finally, he is an honorary member of the Spanish Society of Gastrointestinal Radiology (SEDIA). The main focus of his research is the development and validation of imaging biomarkers on cancer applications. He recently initiated the development of a Radiomics Network comprising luminary clinical sites in the US and Europe to advance research in that area of Radiomics. He is the section editor on AI, Radiomics, and Machine Learning in Cancer Imaging, and he is the scientific coordinator of a European funded project on AI in prostate cancer (ProCancer-i).